Dexcom technology is more accessible than ever before
NICE (The National Institute for Health and Care Excellence) have guidelines on funding real-time continuous glucose monitoring (CGM) for people with diabetes.
- NICE now recommends that people with type 1 diabetes are offered a choice of a glucose sensor, including real-time CGM.1
- Children and young people with type 1 diabetes should be offered real-time CGM.2
- For people with type 2 diabetes, the recommendation is that real-time CGM can be considered an alternative to intermittent scanning (isCGM). 3
Know what you need
Speaking with your Diabetes Healthcare Team is important to ensure you get the right CGM. There are some things you should consider before your appointment, such as deciding what your goals and needs are.
To help you confidently prepare for your discussion, we have created a handy checklist to fill out and take with you.
'As a parent of a child with Type 1, you have to learn to be flexible. There were so many times, especially when she was first diagnosed, when it felt like our lives had to fit around Ava’s disease…not the other way around. When we got on Dexcom CGM System, it was like the weight was lifted. We finally have a tool to help us get more control.'
Rebecca,
Mum to Dexcom Warrior Ava
Mum to Dexcom Warrior Ava
Real-time makes a real difference
With Dexcom real-time Continuous Glucose Monitoring (CGM) technology, you receive glucose readings right on your compatible smartphone† or optional receiver.‡
Customisable alerts and alarms help keep you in range throughout the day – without finger pricks* or scanning.
Know your numbers
Dexcom real-time CGM devices help you to understand how food, exercise, stress, and more can affect your glucose levels. So you can confidently make more informed decisions about your diabetes.
In sync with your glucose levels –whenever, wherever
Dexcom real-time CGM devices are proven to lower HbA1c4, increase time in range and improve overall wellbeing.5-8 All with no scanning, ever.
With multiple wear locations, customisable alerts and alert schedules, you can personalise your Dexcom CGM system to suit your lifestyle.
Whatever your diabetes needs are, we have a real-time CGM for you
Which Dexcom real-time CGM device would best suit your needs? The best way to find the right device for you is to talk to your Diabetes Healthcare Team who can discuss what your goals are.
CGM made more accessible
Best for people with T1 or T2 diabetes using insulin, who are looking for an easy and accessible real-time CGM system.
Available on prescription in the UK.
Powerful and simple
Best for people with T1 diabetes who may need extra support, such as people who are hypo unaware, children or pregnant women.
Help understanding diabetes
Diabetes can be overwhelming. Dexcom is proud to partner with prominent diabetes charities such as JDRF and Diabetes UK, who both have a wealth of knowledge and advice on their websites to help you understand your condition.
A charity dedicated to helping people with type 1 diabetes, the Juvenile Diabetes Research Foundation fund world-class medical research to cure, prevent and treat type 1 diabetes.
A charity dedicated to helping people with type 1 diabetes, the Juvenile Diabetes Research Foundation fund world-class medical research to cure, prevent and treat type 1 diabetes.
* If your glucose alerts and readings from a Dexcom CGM system do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† For a list of compatible smart devices, please visit www.dexcom.com/compatibility. Watch can only be used in conjunction with a compatible smartphone.
‡ A receiver can be acquired as an optional display device.
1 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.
2 Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/guidance/ng18.
3 Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.
4 Lind M, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017;317(4):379-387.
5 Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA. 2017;317(4):371-378
6 Beck RW, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial. Ann Intern Med. 2017;167(6):365-374.
7 Welsh JB, et al. Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems. J Diabetes Sci Technol. 2022:19322968221099879.
8 Visser MM, et al. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Lancet Diabetes Endocrinol. 2023;11:96–108.
† For a list of compatible smart devices, please visit www.dexcom.com/compatibility. Watch can only be used in conjunction with a compatible smartphone.
‡ A receiver can be acquired as an optional display device.
1 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.
2 Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/guidance/ng18.
3 Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.
4 Lind M, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017;317(4):379-387.
5 Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA. 2017;317(4):371-378
6 Beck RW, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial. Ann Intern Med. 2017;167(6):365-374.
7 Welsh JB, et al. Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems. J Diabetes Sci Technol. 2022:19322968221099879.
8 Visser MM, et al. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Lancet Diabetes Endocrinol. 2023;11:96–108.